HL7 FHIR JP Core ImplementationGuide
1.1.1 - ci-build Japan flag

HL7 FHIR JP Core ImplementationGuide - Local Development build (v1.1.1). See the Directory of published versions

Resource Profile: JP_Medication - Detailed Descriptions

Active as of 2022-10-24

Definitions for the jp-medication resource profile.

1. Medication
Definition

This resource is primarily used for the identification and definition of a medication for the purposes of prescribing, dispensing, and administering a medication as well as for making statements about medication use.

このResourceは薬剤を処方し、払い出し(調剤)、その投与を定義し、IDを付与するためにまず利用され、薬剤の使用状態を示すためにも使われる。

2. Medication.id
Definition

リソースに対するURLとして使われるリソースの論理ID。この値は一度割り当てられたら変更されることはない。

The logical id of the resource, as used in the URL for the resource. Once assigned, this value never changes.

Comments

ResourceにIDがない時期は、create操作のためにサーバにResourceが送信されている時期だけである。

The only time that a resource does not have an id is when it is being submitted to the server using a create operation.

3. Medication.identifier
Definition

この薬剤に関する業務用のID

Business identifier for this medication.

NoteThis is a business identifier, not a resource identifier (see discussion)
Comments

IDとしてシリアルナンバーを使うこともできる。

The serial number could be included as an identifier.

4. Medication.code
Definition

A code (or set of codes) that specify this medication, or a textual description if no code is available. Usage note: This could be a standard medication code such as a code from RxNorm, SNOMED CT, IDMP etc. It could also be a national or local formulary code, optionally with translations to other code systems.

この薬剤を指定するコード。該当するコードがない場合はテキスト表記。 使用法について注記:日本ではHOTコードを利用することが推奨される。一般的な薬剤コードとしてRxNorm、SNOMD CT, IDMPなど標準的な医薬品コードを使うことができる。国や地域に特有のローカルコードも使うことができ、他のコードに変換することもできる。

BindingThe codes SHOULD be taken from JP Core MedicationCode ValueSetFor example codes, see SNOMEDCTMedicationCodes

薬品の種類を規定するコード化された概念

A coded concept that defines the type of a medication.

Comments

使われるコンテキストによるが、ユーザ(処方や調剤などを行った人)によって実際にコードが選択されたのであれば、coding.userSelectedはtrueとすることとなる。Codingのデータ型で説明されているように、「ユーザインターフェース(たとえば、選択肢から特定の項目をユーザが選択するような形式)で特定のコードをユーザが選択したのであれば、"userSelected"に記録されてもよい」 ユーザが選択したコードがあれば、その選択がコード変換などで優先される。そのほかのコードは代替のコードシステムか低粒度のコード(たとえば、ベンダー固有の初期値のための一般的なコード)に文字列変換変換するしかない。

Depending on the context of use, the code that was actually selected by the user (prescriber, dispenser, etc.) will have the coding.userSelected set to true. As described in the coding datatype: "A coding may be marked as a "userSelected" if a user selected the particular coded value in a user interface (e.g. the user selects an item in a pick-list). If a user selected coding exists, it is the preferred choice for performing translations etc. Other codes can only be literal translations to alternative code systems, or codes at a lower level of granularity (e.g. a generic code for a vendor-specific primary one).

5. Medication.status
Definition

薬剤が有効に使われているかどうかを指定するコード。

A code to indicate if the medication is in active use.

Control10..1
Comments

このステータスは薬剤がローカルにあるシステム内で薬剤データベースや棚卸表で有効とされているかどうかを識別するためのものである。たとえば、薬剤システムで「ABC病院特製クリーム」といった製剤のために新しい薬剤ファイルを作成されるような場合もある。未来のある時点では、薬剤記録を作成した時にエラーが発生し、ステータスが「entered-in-error」に変化することもありうる。このステータスは薬剤が特定の処方集に記載されているかどうかを指定するためのものではない。薬剤記録が複数の処方集やカタログを参照することも可能であり、それぞれの記録が異なるステータスを持つこともある。

This status is intended to identify if the medication in a local system is in active use within a drug database or inventory. For example, a pharmacy system may create a new drug file record for a compounded product "ABC Hospital Special Cream" with an active status. At some point in the future, it may be determined that the drug record was created with an error and the status is changed to "entered in error". This status is not intended to specify if a medication is part of a particular formulary. It is possible that the drug record may be referenced by multiple formularies or catalogues and each of those entries would have a separate status.

6. Medication.manufacturer
Definition

Describes the details of the manufacturer of the medication product. This is not intended to represent the distributor of a medication product.

医薬品の製造元の詳細を説明する。これは、医薬品の販売業者を表すことを意図したものではない。

TypeReference(JP_Organization|Organization))
7. Medication.form
Definition

TAB | CAP | PWD | SYR | SUP | LQD | OIT | CRM | TPE | INJ + 製品の剤型についての説明。散剤、ドライシロップ(PWD)、錠剤(TAB)、カプセル(CAP)など。

Describes the form of the item. Powder; tablets; capsule.

BindingThe codes SHOULD be taken from JP Core Medication MERIT9 Form ValueSetFor example codes, see SNOMEDCTFormCodes
Comments

もし、Medication ResourceがMedicationRequest Resourceから参照された場合は、これはオーダされた剤型である。Medication ResourceがMedicationDispense Resourceから参照された場合は、払い出された剤型である。MedicationAdministration ResourceからMedication Resourceが参照されていれば、投与された剤型である。

When Medication is referenced from MedicationRequest, this is the ordered form. When Medication is referenced within MedicationDispense, this is the dispensed form. When Medication is referenced within MedicationAdministration, this is administered form.

8. Medication.amount
Definition

パッケージされた製品に含まれる薬剤固有の量。たとえば、同じ力価の製品を指定すれば(たとえば、インスリングラルギン10単位/mL注射液)、この値はパッケージ内での薬剤量(たとえば、3mL, 10mLなど)を明示することになる。

Specific amount of the drug in the packaged product. For example, when specifying a product that has the same strength (For example, Insulin glargine 100 unit per mL solution for injection), this attribute provides additional clarification of the package amount (For example, 3 mL, 10mL, etc.).

TypeRatio(JP_MedicationRatio_Amount)
Comments

比率(Ratio)を表すデータ型は、量(Quantity)と共通単位を使って適切に表現できないときのみに使われるべきである。分母が"1"に固定されているとわかっているような場合は、量(Quantity)を比率(Ratio)の代わりに使うべきである。

9. Medication.ingredient
Definition

この薬剤を構成する特定の重要成分を識別する

Identifies a particular constituent of interest in the product.

Comments

すべての成分を含む必要はない。もし、ある成分が記載されていなくてもその成分が含有されているかどうかを必ずしも意味しない。特定の成分が記載されていても、すべての成分が記載されていると言うことを意味しない。有効成分であるか、有効成分ではないかを指定することは可能である。

The ingredients need not be a complete list. If an ingredient is not specified, this does not indicate whether an ingredient is present or absent. If an ingredient is specified it does not mean that all ingredients are specified. It is possible to specify both inactive and active ingredients.

10. Medication.ingredient.extension
SlicingThis element introduces a set of slices on Medication.ingredient.extension. The slices are unordered and Open, and can be differentiated using the following discriminators:
  • value @ url
11. Medication.ingredient.extension:drugNo
SliceNamedrugNo
Control0..*
TypeExtension(JP_Medication_Ingredient_DrugNo) (Extension Type: integer)
12. Medication.ingredient.item[x]
Definition

有効成分。物質(単純成分)あるいは他の薬剤や処方。

The actual ingredient - either a substance (simple ingredient) or another medication of a medication.

TypeChoice of: , Reference(Substance|Medication))
[x] NoteSee Choice of Data Types for further information about how to use [x]
Requirements

成分は物質(たとえば、アモキシシリン)や、他の薬剤(たとえば、Glaxal Baseなどの合成製品)を参照されることもある。

The ingredient may reference a substance (for example, amoxicillin) or another medication (for example in the case of a compounded product, Glaxal Base).

Comments

すべての用語集はこの一般的な様式を満たさない。場合によっては、情報モデルとしてCodeableConceptや直接Codingを使うべきではなく、テキストやコード、翻訳や事前条件と事後条件でのエレメントの関係などを示すことも適切ではない。

13. Medication.ingredient.isActive
Definition

この成分が薬剤の治療効果に影響するかどうかの指標

Indication of whether this ingredient affects the therapeutic action of the drug.

Indication of whether this ingredient affects the therapeutic action of the drug.

Requirements

Trueであれば、この成分が薬剤の治療効果に影響がある(たとえば有効)ということを示す。 Falseであれば、この成分が薬剤の治療効果に影響がない(たとえば無効)ということを示す。

True indicates that the ingredient affects the therapeutic action of the drug (i.e. active). False indicates that the ingredient does not affect the therapeutic action of the drug (i.e. inactive).

14. Medication.ingredient.strength
Definition

この薬剤中にどの程度の物質が含まれているかを示す。たとえば、1錠あたり250mgなど。これは分子が250mgで分母が1錠である比率を表現している。

Specifies how many (or how much) of the items there are in this Medication. For example, 250 mg per tablet. This is expressed as a ratio where the numerator is 250mg and the denominator is 1 tablet.

Control10..1
TypeRatio(JP_MedicationRatio_Amount)
Comments

Ratioデータ型は2つの数字の関係で示され、Quantityや一般的な単位で適切に表現できない関係を表すときにのみ用いられる。分母の値が「1」で固定されているような値であれば、QuantityがRatioの代わりに用いられるべきである。

15. Medication.ingredient.strength.extension:strengthType
SliceNamestrengthType
Definition

投与量が製剤単位か成分単位かを格納する拡張

Control0..*
TypeExtension(JP_Medication_IngredientStrength_StrengthType) (Extension Type: CodeableConcept)
16. Medication.batch
Definition

薬剤のパッケージ(薬品そのものではない)についての情報。

Information that only applies to packages (not products).

17. Medication.batch.lotNumber
Definition

特定の薬品を含むバッチに割り当てられたロット番号

The assigned lot number of a batch of the specified product.

Comments

FHIRの文字列は1MBを超えるサイズであってはならない(SHALL NOT)。

18. Medication.batch.expirationDate
Definition

この特定のバッチの薬剤の期限が切れるとき

When this specific batch of product will expire.

1. Medication
Definition

This resource is primarily used for the identification and definition of a medication for the purposes of prescribing, dispensing, and administering a medication as well as for making statements about medication use.

このResourceは薬剤を処方し、払い出し(調剤)、その投与を定義し、IDを付与するためにまず利用され、薬剤の使用状態を示すためにも使われる。

Control0..*
InvariantsDefined on this element
dom-2: If the resource is contained in another resource, it SHALL NOT contain nested Resources (: contained.contained.empty())
dom-3: If the resource is contained in another resource, it SHALL be referred to from elsewhere in the resource or SHALL refer to the containing resource (: contained.where((('#'+id in (%resource.descendants().reference | %resource.descendants().as(canonical) | %resource.descendants().as(uri) | %resource.descendants().as(url))) or descendants().where(reference = '#').exists() or descendants().where(as(canonical) = '#').exists() or descendants().where(as(canonical) = '#').exists()).not()).trace('unmatched', id).empty())
dom-4: If a resource is contained in another resource, it SHALL NOT have a meta.versionId or a meta.lastUpdated (: contained.meta.versionId.empty() and contained.meta.lastUpdated.empty())
dom-5: If a resource is contained in another resource, it SHALL NOT have a security label (: contained.meta.security.empty())
dom-6: A resource should have narrative for robust management (: text.`div`.exists())
2. Medication.id
Definition

リソースに対するURLとして使われるリソースの論理ID。この値は一度割り当てられたら変更されることはない。

The logical id of the resource, as used in the URL for the resource. Once assigned, this value never changes.

Control0..1
Typeidstring
Comments

ResourceにIDがない時期は、create操作のためにサーバにResourceが送信されている時期だけである。

The only time that a resource does not have an id is when it is being submitted to the server using a create operation.

3. Medication.implicitRules
Definition

A reference to a set of rules that were followed when the resource was constructed, and which must be understood when processing the content. Often, this is a reference to an implementation guide that defines the special rules along with other profiles etc.

Control0..1
Typeuri
Is Modifiertrue
Comments

Asserting this rule set restricts the content to be only understood by a limited set of trading partners. This inherently limits the usefulness of the data in the long term. However, the existing health eco-system is highly fractured, and not yet ready to define, collect, and exchange data in a generally computable sense. Wherever possible, implementers and/or specification writers should avoid using this element. Often, when used, the URL is a reference to an implementation guide that defines these special rules as part of it's narrative along with other profiles, value sets, etc.

InvariantsDefined on this element
ele-1: All FHIR elements must have a @value or children (: hasValue() or (children().count() > id.count()))
4. Medication.modifierExtension
Definition

May be used to represent additional information that is not part of the basic definition of the resource and that modifies the understanding of the element that contains it and/or the understanding of the containing element's descendants. Usually modifier elements provide negation or qualification. To make the use of extensions safe and manageable, there is a strict set of governance applied to the definition and use of extensions. Though any implementer is allowed to define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension. Applications processing a resource are required to check for modifier extensions.

Modifier extensions SHALL NOT change the meaning of any elements on Resource or DomainResource (including cannot change the meaning of modifierExtension itself).

Control0..*
TypeExtension
Is Modifiertrue
Requirements

Modifier extensions allow for extensions that cannot be safely ignored to be clearly distinguished from the vast majority of extensions which can be safely ignored. This promotes interoperability by eliminating the need for implementers to prohibit the presence of extensions. For further information, see the definition of modifier extensions.

Alternate Namesextensions, user content
Comments

There can be no stigma associated with the use of extensions by any application, project, or standard - regardless of the institution or jurisdiction that uses or defines the extensions. The use of extensions is what allows the FHIR specification to retain a core level of simplicity for everyone.

InvariantsDefined on this element
ele-1: All FHIR elements must have a @value or children (: hasValue() or (children().count() > id.count()))
ext-1: Must have either extensions or value[x], not both (: extension.exists() != value.exists())
5. Medication.identifier
Definition

この薬剤に関する業務用のID

Business identifier for this medication.

NoteThis is a business identifier, not a resource identifier (see discussion)
Control0..*
TypeIdentifier
Comments

IDとしてシリアルナンバーを使うこともできる。

The serial number could be included as an identifier.

InvariantsDefined on this element
ele-1: All FHIR elements must have a @value or children (: hasValue() or (children().count() > id.count()))
6. Medication.code
Definition

A code (or set of codes) that specify this medication, or a textual description if no code is available. Usage note: This could be a standard medication code such as a code from RxNorm, SNOMED CT, IDMP etc. It could also be a national or local formulary code, optionally with translations to other code systems.

この薬剤を指定するコード。該当するコードがない場合はテキスト表記。 使用法について注記:日本ではHOTコードを利用することが推奨される。一般的な薬剤コードとしてRxNorm、SNOMD CT, IDMPなど標準的な医薬品コードを使うことができる。国や地域に特有のローカルコードも使うことができ、他のコードに変換することもできる。

Control0..1
BindingThe codes SHOULD be taken from JP Core MedicationCode ValueSetFor example codes, see SNOMEDCTMedicationCodes

薬品の種類を規定するコード化された概念

A coded concept that defines the type of a medication.

TypeCodeableConcept
Comments

使われるコンテキストによるが、ユーザ(処方や調剤などを行った人)によって実際にコードが選択されたのであれば、coding.userSelectedはtrueとすることとなる。Codingのデータ型で説明されているように、「ユーザインターフェース(たとえば、選択肢から特定の項目をユーザが選択するような形式)で特定のコードをユーザが選択したのであれば、"userSelected"に記録されてもよい」 ユーザが選択したコードがあれば、その選択がコード変換などで優先される。そのほかのコードは代替のコードシステムか低粒度のコード(たとえば、ベンダー固有の初期値のための一般的なコード)に文字列変換変換するしかない。

Depending on the context of use, the code that was actually selected by the user (prescriber, dispenser, etc.) will have the coding.userSelected set to true. As described in the coding datatype: "A coding may be marked as a "userSelected" if a user selected the particular coded value in a user interface (e.g. the user selects an item in a pick-list). If a user selected coding exists, it is the preferred choice for performing translations etc. Other codes can only be literal translations to alternative code systems, or codes at a lower level of granularity (e.g. a generic code for a vendor-specific primary one).

InvariantsDefined on this element
ele-1: All FHIR elements must have a @value or children (: hasValue() or (children().count() > id.count()))
7. Medication.status
Definition

薬剤が有効に使われているかどうかを指定するコード。

A code to indicate if the medication is in active use.

Control10..1
BindingThe codes SHALL be taken from Medication Status Codes

A coded concept defining if the medication is in active use.

Typecode
Is Modifiertrue
Comments

このステータスは薬剤がローカルにあるシステム内で薬剤データベースや棚卸表で有効とされているかどうかを識別するためのものである。たとえば、薬剤システムで「ABC病院特製クリーム」といった製剤のために新しい薬剤ファイルを作成されるような場合もある。未来のある時点では、薬剤記録を作成した時にエラーが発生し、ステータスが「entered-in-error」に変化することもありうる。このステータスは薬剤が特定の処方集に記載されているかどうかを指定するためのものではない。薬剤記録が複数の処方集やカタログを参照することも可能であり、それぞれの記録が異なるステータスを持つこともある。

This status is intended to identify if the medication in a local system is in active use within a drug database or inventory. For example, a pharmacy system may create a new drug file record for a compounded product "ABC Hospital Special Cream" with an active status. At some point in the future, it may be determined that the drug record was created with an error and the status is changed to "entered in error". This status is not intended to specify if a medication is part of a particular formulary. It is possible that the drug record may be referenced by multiple formularies or catalogues and each of those entries would have a separate status.

InvariantsDefined on this element
ele-1: All FHIR elements must have a @value or children (: hasValue() or (children().count() > id.count()))
8. Medication.manufacturer
Definition

Describes the details of the manufacturer of the medication product. This is not intended to represent the distributor of a medication product.

医薬品の製造元の詳細を説明する。これは、医薬品の販売業者を表すことを意図したものではない。

Control0..1
TypeReference(JP_Organization|Organization))
InvariantsDefined on this element
ele-1: All FHIR elements must have a @value or children (: hasValue() or (children().count() > id.count()))
9. Medication.form
Definition

TAB | CAP | PWD | SYR | SUP | LQD | OIT | CRM | TPE | INJ + 製品の剤型についての説明。散剤、ドライシロップ(PWD)、錠剤(TAB)、カプセル(CAP)など。

Describes the form of the item. Powder; tablets; capsule.

Control0..1
BindingThe codes SHOULD be taken from JP Core Medication MERIT9 Form ValueSetFor example codes, see SNOMEDCTFormCodes
TypeCodeableConcept
Comments

もし、Medication ResourceがMedicationRequest Resourceから参照された場合は、これはオーダされた剤型である。Medication ResourceがMedicationDispense Resourceから参照された場合は、払い出された剤型である。MedicationAdministration ResourceからMedication Resourceが参照されていれば、投与された剤型である。

When Medication is referenced from MedicationRequest, this is the ordered form. When Medication is referenced within MedicationDispense, this is the dispensed form. When Medication is referenced within MedicationAdministration, this is administered form.

InvariantsDefined on this element
ele-1: All FHIR elements must have a @value or children (: hasValue() or (children().count() > id.count()))
10. Medication.amount
Definition

パッケージされた製品に含まれる薬剤固有の量。たとえば、同じ力価の製品を指定すれば(たとえば、インスリングラルギン10単位/mL注射液)、この値はパッケージ内での薬剤量(たとえば、3mL, 10mLなど)を明示することになる。

Specific amount of the drug in the packaged product. For example, when specifying a product that has the same strength (For example, Insulin glargine 100 unit per mL solution for injection), this attribute provides additional clarification of the package amount (For example, 3 mL, 10mL, etc.).

Control0..1 This element is affected by the following invariants: ele-1
TypeRatio(JP_MedicationRatio_Amount)
Comments

比率(Ratio)を表すデータ型は、量(Quantity)と共通単位を使って適切に表現できないときのみに使われるべきである。分母が"1"に固定されているとわかっているような場合は、量(Quantity)を比率(Ratio)の代わりに使うべきである。

InvariantsDefined on this element
ele-1: All FHIR elements must have a @value or children (: hasValue() or (children().count() > id.count()))
rat-1: Numerator and denominator SHALL both be present, or both are absent. If both are absent, there SHALL be some extension present (: (numerator.empty() xor denominator.exists()) and (numerator.exists() or extension.exists()))
11. Medication.ingredient
Definition

この薬剤を構成する特定の重要成分を識別する

Identifies a particular constituent of interest in the product.

Control0..*
TypeBackboneElement
Comments

すべての成分を含む必要はない。もし、ある成分が記載されていなくてもその成分が含有されているかどうかを必ずしも意味しない。特定の成分が記載されていても、すべての成分が記載されていると言うことを意味しない。有効成分であるか、有効成分ではないかを指定することは可能である。

The ingredients need not be a complete list. If an ingredient is not specified, this does not indicate whether an ingredient is present or absent. If an ingredient is specified it does not mean that all ingredients are specified. It is possible to specify both inactive and active ingredients.

InvariantsDefined on this element
ele-1: All FHIR elements must have a @value or children (: hasValue() or (children().count() > id.count()))
12. Medication.ingredient.extension
Definition

An Extension

May be used to represent additional information that is not part of the basic definition of the element. To make the use of extensions safe and manageable, there is a strict set of governance applied to the definition and use of extensions. Though any implementer can define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension.

Control0..*
TypeExtension
Alternate Namesextensions, user content
Comments

There can be no stigma associated with the use of extensions by any application, project, or standard - regardless of the institution or jurisdiction that uses or defines the extensions. The use of extensions is what allows the FHIR specification to retain a core level of simplicity for everyone.

InvariantsDefined on this element
ele-1: All FHIR elements must have a @value or children (: hasValue() or (children().count() > id.count()))
ext-1: Must have either extensions or value[x], not both (: extension.exists() != value.exists())
SlicingThis element introduces a set of slices on Medication.ingredient.extension. The slices are unordered and Open, and can be differentiated using the following discriminators:
  • value @ url
13. Medication.ingredient.extension:drugNo
SliceNamedrugNo
Definition

RP内の薬剤の連番

Control0..* This element is affected by the following invariants: ele-1
TypeExtension(JP_Medication_Ingredient_DrugNo) (Extension Type: integer)
InvariantsDefined on this element
ele-1: All FHIR elements must have a @value or children (: hasValue() or (children().count() > id.count()))
ext-1: Must have either extensions or value[x], not both (: extension.exists() != value.exists())
14. Medication.ingredient.modifierExtension
Definition

May be used to represent additional information that is not part of the basic definition of the element and that modifies the understanding of the element in which it is contained and/or the understanding of the containing element's descendants. Usually modifier elements provide negation or qualification. To make the use of extensions safe and manageable, there is a strict set of governance applied to the definition and use of extensions. Though any implementer can define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension. Applications processing a resource are required to check for modifier extensions.

Modifier extensions SHALL NOT change the meaning of any elements on Resource or DomainResource (including cannot change the meaning of modifierExtension itself).

Control0..*
TypeExtension
Is Modifiertrue
Requirements

Modifier extensions allow for extensions that cannot be safely ignored to be clearly distinguished from the vast majority of extensions which can be safely ignored. This promotes interoperability by eliminating the need for implementers to prohibit the presence of extensions. For further information, see the definition of modifier extensions.

Alternate Namesextensions, user content, modifiers
Comments

There can be no stigma associated with the use of extensions by any application, project, or standard - regardless of the institution or jurisdiction that uses or defines the extensions. The use of extensions is what allows the FHIR specification to retain a core level of simplicity for everyone.

InvariantsDefined on this element
ele-1: All FHIR elements must have a @value or children (: hasValue() or (children().count() > id.count()))
ext-1: Must have either extensions or value[x], not both (: extension.exists() != value.exists())
15. Medication.ingredient.item[x]
Definition

有効成分。物質(単純成分)あるいは他の薬剤や処方。

The actual ingredient - either a substance (simple ingredient) or another medication of a medication.

Control1..1
TypeChoice of: CodeableConcept, Reference(Substance|Medication))
[x] NoteSee Choice of Data Types for further information about how to use [x]
Requirements

成分は物質(たとえば、アモキシシリン)や、他の薬剤(たとえば、Glaxal Baseなどの合成製品)を参照されることもある。

The ingredient may reference a substance (for example, amoxicillin) or another medication (for example in the case of a compounded product, Glaxal Base).

Comments

すべての用語集はこの一般的な様式を満たさない。場合によっては、情報モデルとしてCodeableConceptや直接Codingを使うべきではなく、テキストやコード、翻訳や事前条件と事後条件でのエレメントの関係などを示すことも適切ではない。

InvariantsDefined on this element
ele-1: All FHIR elements must have a @value or children (: hasValue() or (children().count() > id.count()))
16. Medication.ingredient.isActive
Definition

この成分が薬剤の治療効果に影響するかどうかの指標

Indication of whether this ingredient affects the therapeutic action of the drug.

Indication of whether this ingredient affects the therapeutic action of the drug.

Control0..1
Typeboolean
Requirements

Trueであれば、この成分が薬剤の治療効果に影響がある(たとえば有効)ということを示す。 Falseであれば、この成分が薬剤の治療効果に影響がない(たとえば無効)ということを示す。

True indicates that the ingredient affects the therapeutic action of the drug (i.e. active). False indicates that the ingredient does not affect the therapeutic action of the drug (i.e. inactive).

InvariantsDefined on this element
ele-1: All FHIR elements must have a @value or children (: hasValue() or (children().count() > id.count()))
17. Medication.ingredient.strength
Definition

この薬剤中にどの程度の物質が含まれているかを示す。たとえば、1錠あたり250mgなど。これは分子が250mgで分母が1錠である比率を表現している。

Specifies how many (or how much) of the items there are in this Medication. For example, 250 mg per tablet. This is expressed as a ratio where the numerator is 250mg and the denominator is 1 tablet.

Control10..1 This element is affected by the following invariants: ele-1
TypeRatio(JP_MedicationRatio_Amount)
Comments

Ratioデータ型は2つの数字の関係で示され、Quantityや一般的な単位で適切に表現できない関係を表すときにのみ用いられる。分母の値が「1」で固定されているような値であれば、QuantityがRatioの代わりに用いられるべきである。

InvariantsDefined on this element
ele-1: All FHIR elements must have a @value or children (: hasValue() or (children().count() > id.count()))
rat-1: Numerator and denominator SHALL both be present, or both are absent. If both are absent, there SHALL be some extension present (: (numerator.empty() xor denominator.exists()) and (numerator.exists() or extension.exists()))
18. Medication.ingredient.strength.extension:strengthType
SliceNamestrengthType
Definition

投与量が製剤単位か成分単位かを格納する拡張

Control0..*
TypeExtension(JP_Medication_IngredientStrength_StrengthType) (Extension Type: CodeableConcept)
InvariantsDefined on this element
ele-1: All FHIR elements must have a @value or children (: hasValue() or (children().count() > id.count()))
ext-1: Must have either extensions or value[x], not both (: extension.exists() != value.exists())
19. Medication.batch
Definition

薬剤のパッケージ(薬品そのものではない)についての情報。

Information that only applies to packages (not products).

Control0..1
TypeBackboneElement
InvariantsDefined on this element
ele-1: All FHIR elements must have a @value or children (: hasValue() or (children().count() > id.count()))
20. Medication.batch.modifierExtension
Definition

May be used to represent additional information that is not part of the basic definition of the element and that modifies the understanding of the element in which it is contained and/or the understanding of the containing element's descendants. Usually modifier elements provide negation or qualification. To make the use of extensions safe and manageable, there is a strict set of governance applied to the definition and use of extensions. Though any implementer can define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension. Applications processing a resource are required to check for modifier extensions.

Modifier extensions SHALL NOT change the meaning of any elements on Resource or DomainResource (including cannot change the meaning of modifierExtension itself).

Control0..*
TypeExtension
Is Modifiertrue
Requirements

Modifier extensions allow for extensions that cannot be safely ignored to be clearly distinguished from the vast majority of extensions which can be safely ignored. This promotes interoperability by eliminating the need for implementers to prohibit the presence of extensions. For further information, see the definition of modifier extensions.

Alternate Namesextensions, user content, modifiers
Comments

There can be no stigma associated with the use of extensions by any application, project, or standard - regardless of the institution or jurisdiction that uses or defines the extensions. The use of extensions is what allows the FHIR specification to retain a core level of simplicity for everyone.

InvariantsDefined on this element
ele-1: All FHIR elements must have a @value or children (: hasValue() or (children().count() > id.count()))
ext-1: Must have either extensions or value[x], not both (: extension.exists() != value.exists())
21. Medication.batch.lotNumber
Definition

特定の薬品を含むバッチに割り当てられたロット番号

The assigned lot number of a batch of the specified product.

Control0..1
Typestring
Comments

FHIRの文字列は1MBを超えるサイズであってはならない(SHALL NOT)。

InvariantsDefined on this element
ele-1: All FHIR elements must have a @value or children (: hasValue() or (children().count() > id.count()))
22. Medication.batch.expirationDate
Definition

この特定のバッチの薬剤の期限が切れるとき

When this specific batch of product will expire.

Control0..1
TypedateTime
InvariantsDefined on this element
ele-1: All FHIR elements must have a @value or children (: hasValue() or (children().count() > id.count()))
1. Medication
Definition

This resource is primarily used for the identification and definition of a medication for the purposes of prescribing, dispensing, and administering a medication as well as for making statements about medication use.

このResourceは薬剤を処方し、払い出し(調剤)、その投与を定義し、IDを付与するためにまず利用され、薬剤の使用状態を示すためにも使われる。

Control0..*
2. Medication.id
Definition

リソースに対するURLとして使われるリソースの論理ID。この値は一度割り当てられたら変更されることはない。

Control0..1
Typeid
Comments

ResourceにIDがない時期は、create操作のためにサーバにResourceが送信されている時期だけである。

3. Medication.meta
Definition

The metadata about the resource. This is content that is maintained by the infrastructure. Changes to the content might not always be associated with version changes to the resource.

Control0..1
TypeMeta
InvariantsDefined on this element
ele-1: All FHIR elements must have a @value or children (: hasValue() or (children().count() > id.count()))
4. Medication.implicitRules
Definition

A reference to a set of rules that were followed when the resource was constructed, and which must be understood when processing the content. Often, this is a reference to an implementation guide that defines the special rules along with other profiles etc.

Control0..1
Typeuri
Is Modifiertrue
Comments

Asserting this rule set restricts the content to be only understood by a limited set of trading partners. This inherently limits the usefulness of the data in the long term. However, the existing health eco-system is highly fractured, and not yet ready to define, collect, and exchange data in a generally computable sense. Wherever possible, implementers and/or specification writers should avoid using this element. Often, when used, the URL is a reference to an implementation guide that defines these special rules as part of it's narrative along with other profiles, value sets, etc.

InvariantsDefined on this element
ele-1: All FHIR elements must have a @value or children (: hasValue() or (children().count() > id.count()))
5. Medication.language
Definition

The base language in which the resource is written.

Control0..1
BindingThe codes SHOULD be taken from CommonLanguages A human language
Additional BindingsPurpose
AllLanguagesMax Binding
Typecode
Comments

Language is provided to support indexing and accessibility (typically, services such as text to speech use the language tag). The html language tag in the narrative applies to the narrative. The language tag on the resource may be used to specify the language of other presentations generated from the data in the resource. Not all the content has to be in the base language. The Resource.language should not be assumed to apply to the narrative automatically. If a language is specified, it should it also be specified on the div element in the html (see rules in HTML5 for information about the relationship between xml:lang and the html lang attribute).

InvariantsDefined on this element
ele-1: All FHIR elements must have a @value or children (: hasValue() or (children().count() > id.count()))
6. Medication.text
Definition

A human-readable narrative that contains a summary of the resource and can be used to represent the content of the resource to a human. The narrative need not encode all the structured data, but is required to contain sufficient detail to make it "clinically safe" for a human to just read the narrative. Resource definitions may define what content should be represented in the narrative to ensure clinical safety.

Control0..1
TypeNarrative
Alternate Namesnarrativehtmlxhtmldisplay
Comments

Contained resources do not have narrative. Resources that are not contained SHOULD have a narrative. In some cases, a resource may only have text with little or no additional discrete data (as long as all minOccurs=1 elements are satisfied). This may be necessary for data from legacy systems where information is captured as a "text blob" or where text is additionally entered raw or narrated and encoded information is added later.

InvariantsDefined on this element
ele-1: All FHIR elements must have a @value or children (: hasValue() or (children().count() > id.count()))
7. Medication.contained
Definition

These resources do not have an independent existence apart from the resource that contains them - they cannot be identified independently, and nor can they have their own independent transaction scope.

Control0..*
TypeResource
Alternate Namesinline resourcesanonymous resourcescontained resources
Comments

This should never be done when the content can be identified properly, as once identification is lost, it is extremely difficult (and context dependent) to restore it again. Contained resources may have profiles and tags In their meta elements, but SHALL NOT have security labels.

8. Medication.extension
Definition

May be used to represent additional information that is not part of the basic definition of the resource. To make the use of extensions safe and manageable, there is a strict set of governance applied to the definition and use of extensions. Though any implementer can define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension.

Control0..*
TypeExtension
Alternate Namesextensionsuser content
Comments

There can be no stigma associated with the use of extensions by any application, project, or standard - regardless of the institution or jurisdiction that uses or defines the extensions. The use of extensions is what allows the FHIR specification to retain a core level of simplicity for everyone.

InvariantsDefined on this element
ele-1: All FHIR elements must have a @value or children (: hasValue() or (children().count() > id.count()))
ext-1: Must have either extensions or value[x], not both (: extension.exists() != value.exists())
9. Medication.modifierExtension
Definition

May be used to represent additional information that is not part of the basic definition of the resource and that modifies the understanding of the element that contains it and/or the understanding of the containing element's descendants. Usually modifier elements provide negation or qualification. To make the use of extensions safe and manageable, there is a strict set of governance applied to the definition and use of extensions. Though any implementer is allowed to define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension. Applications processing a resource are required to check for modifier extensions.

Modifier extensions SHALL NOT change the meaning of any elements on Resource or DomainResource (including cannot change the meaning of modifierExtension itself).

Control0..*
TypeExtension
Is Modifiertrue
Requirements

Modifier extensions allow for extensions that cannot be safely ignored to be clearly distinguished from the vast majority of extensions which can be safely ignored. This promotes interoperability by eliminating the need for implementers to prohibit the presence of extensions. For further information, see the definition of modifier extensions.

Alternate Namesextensionsuser content
Comments

There can be no stigma associated with the use of extensions by any application, project, or standard - regardless of the institution or jurisdiction that uses or defines the extensions. The use of extensions is what allows the FHIR specification to retain a core level of simplicity for everyone.

InvariantsDefined on this element
ele-1: All FHIR elements must have a @value or children (: hasValue() or (children().count() > id.count()))
ext-1: Must have either extensions or value[x], not both (: extension.exists() != value.exists())
10. Medication.identifier
Definition

この薬剤に関する業務用のID

NoteThis is a business identifier, not a resource identifier (see discussion)
Control0..*
TypeIdentifier
Comments

IDとしてシリアルナンバーを使うこともできる。

InvariantsDefined on this element
ele-1: All FHIR elements must have a @value or children (: hasValue() or (children().count() > id.count()))
11. Medication.code
Definition

A code (or set of codes) that specify this medication, or a textual description if no code is available. Usage note: This could be a standard medication code such as a code from RxNorm, SNOMED CT, IDMP etc. It could also be a national or local formulary code, optionally with translations to other code systems.

この薬剤を指定するコード。該当するコードがない場合はテキスト表記。 使用法について注記:日本ではHOTコードを利用することが推奨される。一般的な薬剤コードとしてRxNorm、SNOMD CT, IDMPなど標準的な医薬品コードを使うことができる。国や地域に特有のローカルコードも使うことができ、他のコードに変換することもできる。

Control0..1
BindingThe codes SHOULD be taken from JP Core MedicationCode ValueSet 薬品の種類を規定するコード化された概
TypeCodeableConcept
Comments

使われるコンテキストによるが、ユーザ(処方や調剤などを行った人)によって実際にコードが選択されたのであれば、coding.userSelectedはtrueとすることとなる。Codingのデータ型で説明されているように、「ユーザインターフェース(たとえば、選択肢から特定の項目をユーザが選択するような形式)で特定のコードをユーザが選択したのであれば、"userSelected"に記録されてもよい」 ユーザが選択したコードがあれば、その選択がコード変換などで優先される。そのほかのコードは代替のコードシステムか低粒度のコード(たとえば、ベンダー固有の初期値のための一般的なコード)に文字列変換変換するしかない。

InvariantsDefined on this element
ele-1: All FHIR elements must have a @value or children (: hasValue() or (children().count() > id.count()))
12. Medication.status
Definition

薬剤が有効に使われているかどうかを指定するコード。

Control1..1
BindingThe codes SHALL be taken from Medication Status Codes A coded concept defining if the medication is in active use
Typecode
Is Modifiertrue
Comments

このステータスは薬剤がローカルにあるシステム内で薬剤データベースや棚卸表で有効とされているかどうかを識別するためのものである。たとえば、薬剤システムで「ABC病院特製クリーム」といった製剤のために新しい薬剤ファイルを作成されるような場合もある。未来のある時点では、薬剤記録を作成した時にエラーが発生し、ステータスが「entered-in-error」に変化することもありうる。このステータスは薬剤が特定の処方集に記載されているかどうかを指定するためのものではない。薬剤記録が複数の処方集やカタログを参照することも可能であり、それぞれの記録が異なるステータスを持つこともある。

InvariantsDefined on this element
ele-1: All FHIR elements must have a @value or children (: hasValue() or (children().count() > id.count()))
13. Medication.manufacturer
Definition

Describes the details of the manufacturer of the medication product. This is not intended to represent the distributor of a medication product.

医薬品の製造元の詳細を説明する。これは、医薬品の販売業者を表すことを意図したものではない。

Control0..1
TypeReference(JP_Organization))
InvariantsDefined on this element
ele-1: All FHIR elements must have a @value or children (: hasValue() or (children().count() > id.count()))
14. Medication.form
Definition

TAB | CAP | PWD | SYR | SUP | LQD | OIT | CRM | TPE | INJ + 製品の剤型についての説明。散剤、ドライシロップ(PWD)、錠剤(TAB)、カプセル(CAP)など。

Control0..1
BindingThe codes SHOULD be taken from JP Core Medication MERIT9 Form ValueSet
TypeCodeableConcept
Comments

もし、Medication ResourceがMedicationRequest Resourceから参照された場合は、これはオーダされた剤型である。Medication ResourceがMedicationDispense Resourceから参照された場合は、払い出された剤型である。MedicationAdministration ResourceからMedication Resourceが参照されていれば、投与された剤型である。

InvariantsDefined on this element
ele-1: All FHIR elements must have a @value or children (: hasValue() or (children().count() > id.count()))
15. Medication.amount
Definition

パッケージされた製品に含まれる薬剤固有の量。たとえば、同じ力価の製品を指定すれば(たとえば、インスリングラルギン10単位/mL注射液)、この値はパッケージ内での薬剤量(たとえば、3mL, 10mLなど)を明示することになる。

Control0..1 This element is affected by the following invariants: ele-1
TypeRatio(JP_MedicationRatio_Amount)
Comments

比率(Ratio)を表すデータ型は、量(Quantity)と共通単位を使って適切に表現できないときのみに使われるべきである。分母が"1"に固定されているとわかっているような場合は、量(Quantity)を比率(Ratio)の代わりに使うべきである。

InvariantsDefined on this element
ele-1: All FHIR elements must have a @value or children (: hasValue() or (children().count() > id.count()))
rat-1: Numerator and denominator SHALL both be present, or both are absent. If both are absent, there SHALL be some extension present (: (numerator.empty() xor denominator.exists()) and (numerator.exists() or extension.exists()))
16. Medication.ingredient
Definition

この薬剤を構成する特定の重要成分を識別する

Control0..*
TypeBackboneElement
Comments

すべての成分を含む必要はない。もし、ある成分が記載されていなくてもその成分が含有されているかどうかを必ずしも意味しない。特定の成分が記載されていても、すべての成分が記載されていると言うことを意味しない。有効成分であるか、有効成分ではないかを指定することは可能である。

InvariantsDefined on this element
ele-1: All FHIR elements must have a @value or children (: hasValue() or (children().count() > id.count()))
17. Medication.ingredient.id
Definition

Unique id for the element within a resource (for internal references). This may be any string value that does not contain spaces.

Control0..1
Typestring
XML RepresentationIn the XML format, this property is represented as an attribute.
18. Medication.ingredient.extension
Definition

An Extension

Control0..*
TypeExtension
InvariantsDefined on this element
ele-1: All FHIR elements must have a @value or children (: hasValue() or (children().count() > id.count()))
ext-1: Must have either extensions or value[x], not both (: extension.exists() != value.exists())
SlicingThis element introduces a set of slices on Medication.ingredient.extension. The slices are unordered and Open, and can be differentiated using the following discriminators:
  • value @ url
19. Medication.ingredient.extension:drugNo
SliceNamedrugNo
Definition

RP内の薬剤の連番

Control0..* This element is affected by the following invariants: ele-1
TypeExtension(JP_Medication_Ingredient_DrugNo) (Extension Type: integer)
InvariantsDefined on this element
ele-1: All FHIR elements must have a @value or children (: hasValue() or (children().count() > id.count()))
ext-1: Must have either extensions or value[x], not both (: extension.exists() != value.exists())
20. Medication.ingredient.modifierExtension
Definition

May be used to represent additional information that is not part of the basic definition of the element and that modifies the understanding of the element in which it is contained and/or the understanding of the containing element's descendants. Usually modifier elements provide negation or qualification. To make the use of extensions safe and manageable, there is a strict set of governance applied to the definition and use of extensions. Though any implementer can define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension. Applications processing a resource are required to check for modifier extensions.

Modifier extensions SHALL NOT change the meaning of any elements on Resource or DomainResource (including cannot change the meaning of modifierExtension itself).

Control0..*
TypeExtension
Is Modifiertrue
Requirements

Modifier extensions allow for extensions that cannot be safely ignored to be clearly distinguished from the vast majority of extensions which can be safely ignored. This promotes interoperability by eliminating the need for implementers to prohibit the presence of extensions. For further information, see the definition of modifier extensions.

Alternate Namesextensionsuser contentmodifiers
Comments

There can be no stigma associated with the use of extensions by any application, project, or standard - regardless of the institution or jurisdiction that uses or defines the extensions. The use of extensions is what allows the FHIR specification to retain a core level of simplicity for everyone.

InvariantsDefined on this element
ele-1: All FHIR elements must have a @value or children (: hasValue() or (children().count() > id.count()))
ext-1: Must have either extensions or value[x], not both (: extension.exists() != value.exists())
21. Medication.ingredient.item[x]
Definition

有効成分。物質(単純成分)あるいは他の薬剤や処方。

Control1..1
TypeCodeableConcept
[x] NoteSee Choice of Data Types for further information about how to use [x]
Requirements

成分は物質(たとえば、アモキシシリン)や、他の薬剤(たとえば、Glaxal Baseなどの合成製品)を参照されることもある。

Comments

すべての用語集はこの一般的な様式を満たさない。場合によっては、情報モデルとしてCodeableConceptや直接Codingを使うべきではなく、テキストやコード、翻訳や事前条件と事後条件でのエレメントの関係などを示すことも適切ではない。

InvariantsDefined on this element
ele-1: All FHIR elements must have a @value or children (: hasValue() or (children().count() > id.count()))
22. Medication.ingredient.isActive
Definition

この成分が薬剤の治療効果に影響するかどうかの指標

Indication of whether this ingredient affects the therapeutic action of the drug.

Control0..1
Typeboolean
Requirements

Trueであれば、この成分が薬剤の治療効果に影響がある(たとえば有効)ということを示す。 Falseであれば、この成分が薬剤の治療効果に影響がない(たとえば無効)ということを示す。

InvariantsDefined on this element
ele-1: All FHIR elements must have a @value or children (: hasValue() or (children().count() > id.count()))
23. Medication.ingredient.strength
Definition

この薬剤中にどの程度の物質が含まれているかを示す。たとえば、1錠あたり250mgなど。これは分子が250mgで分母が1錠である比率を表現している。

Control1..1 This element is affected by the following invariants: ele-1
TypeRatio(JP_MedicationRatio_Amount)
Comments

Ratioデータ型は2つの数字の関係で示され、Quantityや一般的な単位で適切に表現できない関係を表すときにのみ用いられる。分母の値が「1」で固定されているような値であれば、QuantityがRatioの代わりに用いられるべきである。

InvariantsDefined on this element
ele-1: All FHIR elements must have a @value or children (: hasValue() or (children().count() > id.count()))
rat-1: Numerator and denominator SHALL both be present, or both are absent. If both are absent, there SHALL be some extension present (: (numerator.empty() xor denominator.exists()) and (numerator.exists() or extension.exists()))
24. Medication.ingredient.strength.id
Definition

Unique id for the element within a resource (for internal references). This may be any string value that does not contain spaces.

Control0..1
Typestring
XML RepresentationIn the XML format, this property is represented as an attribute.
25. Medication.ingredient.strength.extension
Definition

May be used to represent additional information that is not part of the basic definition of the element. To make the use of extensions safe and manageable, there is a strict set of governance applied to the definition and use of extensions. Though any implementer can define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension.

Control0..*
TypeExtension
Alternate Namesextensionsuser content
Comments

There can be no stigma associated with the use of extensions by any application, project, or standard - regardless of the institution or jurisdiction that uses or defines the extensions. The use of extensions is what allows the FHIR specification to retain a core level of simplicity for everyone.

InvariantsDefined on this element
ele-1: All FHIR elements must have a @value or children (: hasValue() or (children().count() > id.count()))
ext-1: Must have either extensions or value[x], not both (: extension.exists() != value.exists())
SlicingThis element introduces a set of slices on Medication.ingredient.strength.extension. The slices are unordered and Open, and can be differentiated using the following discriminators:
  • value @ url
26. Medication.ingredient.strength.extension:strengthType
SliceNamestrengthType
Definition

投与量が製剤単位か成分単位かを格納する拡張

Control0..*
TypeExtension(JP_Medication_IngredientStrength_StrengthType) (Extension Type: CodeableConcept)
InvariantsDefined on this element
ele-1: All FHIR elements must have a @value or children (: hasValue() or (children().count() > id.count()))
ext-1: Must have either extensions or value[x], not both (: extension.exists() != value.exists())
27. Medication.ingredient.strength.numerator
Definition

薬剤に関する数量と単位を定めたデータイプ

Control0..1 This element is affected by the following invariants: ele-1
TypeQuantity(JP_MedicationQuantity)
Comments

薬剤に関する数量と単位を定めている。ValueおよびCodeを必須としている。単位についてはMERIT9医薬品単位略号の利用を推進している。(SHOULD)

InvariantsDefined on this element
ele-1: All FHIR elements must have a @value or children (: hasValue() or (children().count() > id.count()))
qty-3: If a code for the unit is present, the system SHALL also be present (: code.empty() or system.exists())
28. Medication.ingredient.strength.denominator
Definition

薬剤に関する数量と単位を定めたデータイプ

Control0..1 This element is affected by the following invariants: ele-1
TypeQuantity(JP_MedicationQuantity)
Comments

薬剤に関する数量と単位を定めている。ValueおよびCodeを必須としている。単位についてはMERIT9医薬品単位略号の利用を推進している。(SHOULD)

InvariantsDefined on this element
ele-1: All FHIR elements must have a @value or children (: hasValue() or (children().count() > id.count()))
qty-3: If a code for the unit is present, the system SHALL also be present (: code.empty() or system.exists())
29. Medication.batch
Definition

薬剤のパッケージ(薬品そのものではない)についての情報。

Control0..1
TypeBackboneElement
InvariantsDefined on this element
ele-1: All FHIR elements must have a @value or children (: hasValue() or (children().count() > id.count()))
30. Medication.batch.id
Definition

Unique id for the element within a resource (for internal references). This may be any string value that does not contain spaces.

Control0..1
Typestring
XML RepresentationIn the XML format, this property is represented as an attribute.
31. Medication.batch.extension
Definition

May be used to represent additional information that is not part of the basic definition of the element. To make the use of extensions safe and manageable, there is a strict set of governance applied to the definition and use of extensions. Though any implementer can define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension.

Control0..*
TypeExtension
Alternate Namesextensionsuser content
Comments

There can be no stigma associated with the use of extensions by any application, project, or standard - regardless of the institution or jurisdiction that uses or defines the extensions. The use of extensions is what allows the FHIR specification to retain a core level of simplicity for everyone.

InvariantsDefined on this element
ele-1: All FHIR elements must have a @value or children (: hasValue() or (children().count() > id.count()))
ext-1: Must have either extensions or value[x], not both (: extension.exists() != value.exists())
32. Medication.batch.modifierExtension
Definition

May be used to represent additional information that is not part of the basic definition of the element and that modifies the understanding of the element in which it is contained and/or the understanding of the containing element's descendants. Usually modifier elements provide negation or qualification. To make the use of extensions safe and manageable, there is a strict set of governance applied to the definition and use of extensions. Though any implementer can define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension. Applications processing a resource are required to check for modifier extensions.

Modifier extensions SHALL NOT change the meaning of any elements on Resource or DomainResource (including cannot change the meaning of modifierExtension itself).

Control0..*
TypeExtension
Is Modifiertrue
Requirements

Modifier extensions allow for extensions that cannot be safely ignored to be clearly distinguished from the vast majority of extensions which can be safely ignored. This promotes interoperability by eliminating the need for implementers to prohibit the presence of extensions. For further information, see the definition of modifier extensions.

Alternate Namesextensionsuser contentmodifiers
Comments

There can be no stigma associated with the use of extensions by any application, project, or standard - regardless of the institution or jurisdiction that uses or defines the extensions. The use of extensions is what allows the FHIR specification to retain a core level of simplicity for everyone.

InvariantsDefined on this element
ele-1: All FHIR elements must have a @value or children (: hasValue() or (children().count() > id.count()))
ext-1: Must have either extensions or value[x], not both (: extension.exists() != value.exists())
33. Medication.batch.lotNumber
Definition

特定の薬品を含むバッチに割り当てられたロット番号

Control0..1
Typestring
Comments

FHIRの文字列は1MBを超えるサイズであってはならない(SHALL NOT)。

InvariantsDefined on this element
ele-1: All FHIR elements must have a @value or children (: hasValue() or (children().count() > id.count()))
34. Medication.batch.expirationDate
Definition

この特定のバッチの薬剤の期限が切れるとき

Control0..1
TypedateTime
InvariantsDefined on this element
ele-1: All FHIR elements must have a @value or children (: hasValue() or (children().count() > id.count()))